Clinical
Phase I studies
- Alzheimer’s disease (Including FIH)Top 2 in number of subjects enrolled globally.
- Glaucoma, ocular hypertension,
- Type1 DM, Type2 DM
- Healthy volunteers (including FIH),30-days admission, DDI studies, etc.
- Healthy elderly volunteers48 beds occupied at a time, 24-days of admission
Phase II, III studies
- Pre-Alzheimer’s diseasePsychiatrist and clinical psychologist
- Type1 DM, Type2 DM
- Bronchial asthma12-hour repeated spirometry
- Osteoarthritis53 subjects enrolled in 4 months.
Patient PK studies and others
- Hyperuricemia24 subjects with overproduction of uric acid.Obtained 380 written informed consents in 10 months.
- Chemotherapeutics for cancer patients
- Bronchial asthma12-hour repeated spirometry
- BE study for Post-menopausal women360 subjects (180 × 2 times)
